Dr Uppals Testing And Analytical Laboratory Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-11-2024
- Paid Up Capital ₹ 0.10 M
as on 01-11-2024
- Company Age 24 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 101.11%
(FY 2023)
- Profit 146.74%
(FY 2023)
- Ebitda 135.73%
(FY 2023)
- Net Worth 13.76%
(FY 2023)
- Total Assets 11.64%
(FY 2023)
About Dr Uppals Testing And Analytical Laboratory
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yoginder Sharma and Sanjeev Chauhan serve as directors at the Company.
- CIN/LLPIN
U93090CH2000PTC023988
- Company No.
023988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr Uppals Testing And Analytical Laboratory?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yoginder Sharma  | Managing Director | 30-Nov-2006 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjeev Chauhan | Director | 03-Jan-2008 | Current |
Financial Performance of Dr Uppals Testing And Analytical Laboratory.
Dr Uppals Testing And Analytical Laboratory Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 101.11% increase. The company also saw a substantial improvement in profitability, with a 146.74% increase in profit. The company's net worth Soared by an impressive increase of 13.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Uppals Testing And Analytical Laboratory?
Unlock access to Dr Uppals Testing And Analytical Laboratory's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vidwat Institute For Dhyan Yagya Archanadi Private LimitedActive 6 years 2 monthsYoginder Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr Uppals Testing And Analytical Laboratory?
Unlock and access historical data on people associated with Dr Uppals Testing And Analytical Laboratory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Uppals Testing And Analytical Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Uppals Testing And Analytical Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
